rs1194707294
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001387283.1(SMARCA4):c.3409A>C(p.Met1137Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M1137V) has been classified as Likely benign.
Frequency
Consequence
NM_001387283.1 missense
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.3409A>C | p.Met1137Leu | missense_variant | Exon 25 of 36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.3409A>C | p.Met1137Leu | missense_variant | Exon 25 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.3409A>C | p.Met1137Leu | missense_variant | Exon 25 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.3409A>C | p.Met1137Leu | missense_variant | Exon 25 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.3409A>C | p.Met1137Leu | missense_variant | Exon 25 of 35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.3409A>C | p.Met1137Leu | missense_variant | Exon 26 of 35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.3409A>C | p.Met1137Leu | missense_variant | Exon 25 of 34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.3409A>C | p.Met1137Leu | missense_variant | Exon 25 of 34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.3409A>C | p.Met1137Leu | missense_variant | Exon 26 of 35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.2821A>C | p.Met941Leu | missense_variant | Exon 22 of 32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.2053A>C | p.Met685Leu | missense_variant | Exon 18 of 28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.2134A>C | p.Met712Leu | missense_variant | Exon 18 of 27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.1894A>C | p.Met632Leu | missense_variant | Exon 17 of 27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.1762A>C | p.Met588Leu | missense_variant | Exon 16 of 25 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
The p.M1137L variant (also known as c.3409A>C), located in coding exon 24 of the SMARCA4 gene, results from an A to C substitution at nucleotide position 3409. The methionine at codon 1137 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Missense and in-frame variants in SMARCA4 are known to cause neurodevelopmental disorders; however, such associations with rhabdoid tumor predisposition syndrome including small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) are exceedingly rare (Kosho T et al. Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75; Jelinic P et al. Nat Genet. 2014 May;46(5):424-6). Based on the supporting evidence, the association of this alteration with Coffin-Siris syndrome is unknown; however, the association of this alteration with rhabdoid tumor predisposition syndrome is unlikely. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at